Inlyta 5Mg C/60 Comp
Axitinibe is a 5 mg oral tablet for advanced clear cell renal cell carcinoma. It inhibits VEGFR and is taken twice daily.
- The description claims axitinibe inhibits VEGFR.
AI Readiness
Good foundation, but some important product data is still missing.
80%